vs
Side-by-side financial comparison of BTCS Inc. (BTCS) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $7.1M, roughly 1.3× BTCS Inc.). On growth, BTCS Inc. posted the faster year-over-year revenue change (205.5% vs 0.9%). Cytosorbents Corp produced more free cash flow last quarter ($-4.9M vs $-9.8M). Over the past eight quarters, BTCS Inc.'s revenue compounded faster (296.4% CAGR vs 1.3%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
BTCS vs CTSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.1M | $9.2M |
| Net Profit | — | $-5.5M |
| Gross Margin | 12.4% | 73.7% |
| Operating Margin | — | -47.5% |
| Net Margin | — | -59.5% |
| Revenue YoY | 205.5% | 0.9% |
| Net Profit YoY | — | 27.4% |
| EPS (diluted) | $-1.58 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.1M | $9.2M | ||
| Q3 25 | $4.9M | $9.5M | ||
| Q2 25 | $2.8M | $9.6M | ||
| Q1 25 | $1.7M | $8.7M | ||
| Q4 24 | $2.3M | $9.2M | ||
| Q3 24 | $739.2K | $8.6M | ||
| Q2 24 | $561.2K | $8.8M | ||
| Q1 24 | $451.4K | $9.0M |
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $65.6M | $-3.2M | ||
| Q2 25 | $3.9M | $1.9M | ||
| Q1 25 | $-17.3M | $-1.5M | ||
| Q4 24 | — | $-7.6M | ||
| Q3 24 | $-9.0M | $-2.8M | ||
| Q2 24 | $-6.7M | $-4.3M | ||
| Q1 24 | $12.3M | $-6.1M |
| Q4 25 | 12.4% | 73.7% | ||
| Q3 25 | 22.0% | 70.3% | ||
| Q2 25 | -2.9% | 70.9% | ||
| Q1 25 | 7.1% | 71.1% | ||
| Q4 24 | 2.9% | 68.4% | ||
| Q3 24 | 26.5% | 61.0% | ||
| Q2 24 | 69.9% | 73.5% | ||
| Q1 24 | 64.4% | 76.5% |
| Q4 25 | — | -47.5% | ||
| Q3 25 | — | -30.2% | ||
| Q2 25 | — | -37.6% | ||
| Q1 25 | — | -44.5% | ||
| Q4 24 | — | -37.1% | ||
| Q3 24 | — | -56.1% | ||
| Q2 24 | — | -40.4% | ||
| Q1 24 | — | -51.8% |
| Q4 25 | — | -59.5% | ||
| Q3 25 | 1328.1% | -33.4% | ||
| Q2 25 | 140.0% | 20.2% | ||
| Q1 25 | -1022.5% | -16.9% | ||
| Q4 24 | — | -82.7% | ||
| Q3 24 | -1223.0% | -32.1% | ||
| Q2 24 | -1198.9% | -48.6% | ||
| Q1 24 | 2715.3% | -67.7% |
| Q4 25 | $-1.58 | $-0.09 | ||
| Q3 25 | $1.30 | $-0.05 | ||
| Q2 25 | $0.14 | $0.03 | ||
| Q1 25 | $-0.86 | $-0.02 | ||
| Q4 24 | $0.28 | $-0.14 | ||
| Q3 24 | $-0.56 | $-0.05 | ||
| Q2 24 | $-0.43 | $-0.08 | ||
| Q1 24 | $0.63 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $6.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.4M | $5.9M |
| Total Assets | $214.6M | $44.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $6.2M | ||
| Q3 25 | $4.5M | $7.5M | ||
| Q2 25 | $639.2K | $10.2M | ||
| Q1 25 | $269.9K | $11.6M | ||
| Q4 24 | $2.0M | $3.3M | ||
| Q3 24 | $254.5K | $5.7M | ||
| Q2 24 | $536.7K | $8.5M | ||
| Q1 24 | $670.6K | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | $139.4M | $5.9M | ||
| Q3 25 | $225.4M | $9.0M | ||
| Q2 25 | $31.1M | $11.6M | ||
| Q1 25 | $20.6M | $14.5M | ||
| Q4 24 | $34.0M | $11.1M | ||
| Q3 24 | $25.2M | $13.4M | ||
| Q2 24 | $33.1M | $17.4M | ||
| Q1 24 | $39.3M | $19.6M |
| Q4 25 | $214.6M | $44.2M | ||
| Q3 25 | $298.9M | $45.8M | ||
| Q2 25 | $40.8M | $48.0M | ||
| Q1 25 | $21.0M | $50.8M | ||
| Q4 24 | $38.2M | $47.4M | ||
| Q3 24 | $26.5M | $47.8M | ||
| Q2 24 | $33.8M | $53.4M | ||
| Q1 24 | $39.5M | $47.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.8M | $-4.8M |
| Free Cash FlowOCF − Capex | $-9.8M | $-4.9M |
| FCF MarginFCF / Revenue | -138.1% | -53.4% |
| Capex IntensityCapex / Revenue | 0.2% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.8M | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.8M | $-4.8M | ||
| Q3 25 | $-2.8M | $-2.6M | ||
| Q2 25 | $-1.3M | $-1.5M | ||
| Q1 25 | $-1.9M | $-3.5M | ||
| Q4 24 | $-3.5M | $-2.3M | ||
| Q3 24 | $-695.2K | $-2.5M | ||
| Q2 24 | $-924.1K | $-4.8M | ||
| Q1 24 | $-769.0K | $-4.8M |
| Q4 25 | $-9.8M | $-4.9M | ||
| Q3 25 | $-2.8M | $-2.6M | ||
| Q2 25 | $-1.3M | $-1.5M | ||
| Q1 25 | $-1.9M | $-3.5M | ||
| Q4 24 | $-3.5M | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-4.9M |
| Q4 25 | -138.1% | -53.4% | ||
| Q3 25 | -56.7% | -27.3% | ||
| Q2 25 | -48.2% | -16.1% | ||
| Q1 25 | -112.7% | -39.7% | ||
| Q4 24 | -152.2% | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -54.4% | ||
| Q1 24 | — | -54.2% |
| Q4 25 | 0.2% | 1.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | 0.1% | 0.4% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.1% | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.34× | -0.78× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTCS
| Builder Plus | $5.9M | 83% |
| Other | $1.2M | 17% |
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
